Norman Molyneux

Part of Redmile Group LLC, Redx Oncology Ltd. is a British biotech company focused on discovering and developing novel targeted medicines for the treatment of cancer and fibrotic disease. The company is based in Macclesfield, UK, and the CEO of the company is Derek Lindsay. The company's focus is on small molecule inhibitors for fibrotic diseases, with preclinical proof of concept demonstrated in lung and kidney fibrosis models. Redx Pharma recently signed an agreement with Jazz Pharmaceuticals for the potential treatment of raf and ras mutant tumors.

The Chartered Institute For Securities & Investment operates as securities and investment educational institute. It is the professional body for those who work in the securities and investment industry in the UK and in a growing number of major financial centres round the world. The company was founded in 1992 and is headquartered in London, the United Kingdom.

AMR Centre Ltd. is a British biotechnology research company founded in 2016. The private company is based in Cheshire, UK. The company conducts research in the field of biotechnology.

Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland.

Gardant Pharmaceuticals, Inc. develops and commercializes pharmaceutical compounds. It develops network for research, clinical development, and project management and guides them through the clinical development and licensing stages. The company was founded in 2000 and is headquartered in New York, NY

ACM Biolabs Pte Ltd. operates as a synthetic biology company which uses its ACM technology platform to allow clients to develop diagnostics, therapeutics and vaccines targeting novel membrane proteins. The company was founded by Madhavan Nallani in 2013 and is headquartered in Singapore.

Vocalink Interchange Network Ltd. provides transaction management services. It forms a hub for the UK's payments infrastructure. It is the transaction management company whose primary focus of attention is switching and settling shared transactions for ATM network. The company processes over 2.4 billion secure transactions per year for the 51 LINK network Members. It provides the legal and commercial framework that makes ATM sharing in the UK via the LINK network. The company is headquartered in Harrogate, the United Kingdom.

VocaLink Ltd. provides electronic financial payment services. Its services include payment processing, access services, banking services, international, and mobile payments. The company was founded in 1968 and is headquartered in Rickmansworth, the United Kingdom.

Carroll Mondon Markets Ltd. provides insurance brokerage services. It offers broking services in the areas of motor fleet, private clients/high-mid net worth, and third party binders. The company was founded in 1832 and is headquartered in London, the United Kingdom.

Part of Vitalhub Corp., Beautiful Information Ltd. is a British company that provides real-time information of patient flow solutions. The company is based in Ashford, UK. Beautiful Information was acquired by The Oakgroup (UK) Ltd. on January 27, 2022 for $2.08 million.

EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom.

Part of Ernst & Young Global Ltd., Arthur Andersen (UK) is a British company that provides accounting services. The company is based in Reading, UK.

Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany.

The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris.

OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany.

BioMedx Group, Inc. operates as a medical technology company transforming the cosmetic surgery consultation services. The firm engages in product development focus on the modeling and simulation of the human face for aesthetic and facial reconstruction applications. The company was founded by Rudy A. Mazzocchi and is headquartered in Baltimore, MD.

Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK.

Vascular Flow Technologies Ltd. develops vascular devices. It offers Spiral Flow Peripheral Vascular Graft, Spiral Flow AV Access Graft, Spiral Laminar Flow, Power of Spiral Laminar Flow and unique design eliminates graft turbulences. The company was founded by Peter Stonebridge, Brian Howlett, Graeme Houston and John B.C. Dick and headquartered in Dundee, the United Kingdom.

Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom.

Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK

Ambicare Health Ltd. manufactures medical products for skin care. The firm develops and commercializes proprietary, light emitting diode (LED) based devices for the treatment skin conditions and diseases. Its ambulatory lighting products offer solutions incorporating OLED (Organic Light Emitting Diode) and LED (Light Emitting Diode) technologies. The products offer battery operated flexible packaged solutions with high light uniformity. The company was founded by James Ferguson and Ifor Samuel in 2004 and is headquartered in Livingston, the United Kingdom.

Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia.

Founded in 1929, Glaxo Laboratories Ltd. is a pharmaceutical wholesaler that is part of GSK Plc. The company is based in London, UK.

Synpromics Agbiosub Ltd. is a British company that engages in research and experimental development on biotechnology. The private company is based in London, UK.

Synpromics Ltd. develops and commercializes synthetic promoters to control gene expressions and regulations. The firm is active in cell and gene therapy, biologics bioprocessing, and industrial biotechnology. The company was founded by Michael L. Robert in 2010 and is headquartered in Edinburgh, the United Kingdom.

QSpine Ltd. designs, manufactures and distributes medical devices in the surgical spine market segment. Its products include Mobi-C, sterispine pedicle screw, sterispine lumber cage and spinetune and shivas cervical cage. The company was founded by Forbes Butterfield and Stuart Hunter Carmichael in 2011 and is headquartered in Corby, the United Kingdom.

Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers.